Motilal Oswal Flexi Cap Fund - Direct Growth
Last updated:
15 February 2026
About
Mutual Fund Type:
Equity
Inception Date:
09 December 2009
AUM/Fund Size:
Rs 13,862.07 Cr
NAV:
Rs 66.12
Total Expense Ratio (TER):
0.82%
Exit Load:
1% if redeemed within 1 year
Benchmark Index:
NIFTY 500 Total Return Index
Risk Level:
Very High
Min SIP:
Rs 500
Fund Manager:
Swapnil Mayekar
Returns
Since Inception:
17.40%
10 Year Returns:
15.00%
5 Year Returns:
14.80%
3 Year Returns:
23.70%
Advanced Ratios
Alpha:
5.93
Beta:
1
Sharpe:
1
Sortino:
1.35
P/E Ratio:
43.4
P/B Ratio:
7.14
Top 3 Holdings & Sectors
Persistent Systems (10.18%)
Coforge (9%)
Kalyan Jewellers (7.03%)
Technology (44.75%)
Industrials (23.56%)
Financial (16.93%)
Equity/ Cash/ Debt Split
Equity:
76.27%
Cash:
4.92%
Debt:
18.81%
Motilal Oswal's QGLP - Quality, Growth, Longevity, Price methodology was reverse-engineered from 30 years of studying what actually made Indian stocks create extraordinary wealth.
Quality examines the business model's competitive strength and management integrity. Growth evaluates earnings trajectory and returns on equity consistency. Longevity assesses how long the competitive advantage is sustainable analysing if this company hold its moat for 10 years or will disruption erode it in three?
Price ensures that even exceptional businesses are purchased at valuations offering a reasonable margin of safety. Critically, QGLP is multiplicative, not additive. If anyone parameter scores zero (say, management integrity is questionable), the entire investment fails the filter regardless of how attractively priced or fast-growing the business appears.
This multiplicative relationship is philosophically borrowed from Charlie Munger's mental model of inversion, and it systematically eliminates the "cheap but terrible business" and "great business but absurdly overpriced" errors that destroy returns for many fund managers.
The companion mantra "Buy Right, Sit Tight" represents the execution philosophy translating QGLP into portfolio behaviour. Raamdeo Agrawal's studies repeatedly demonstrate that India's biggest wealth creators rewarded patient holders over complete business cycles, while frequent trading eroded potential returns through transaction costs, tax friction, and the psychological bias of selling winners too early while holding losers too long.
This philosophy manifests in the fund's deliberately low portfolio turnover. The team resists the temptation to churn holdings in response to short-term market noise, instead focusing on whether the underlying business quality and earnings trajectory remain intact.
One of the most striking structural features and simultaneously the most misunderstood is the fund's concentrated approach, typically investing in just 25-35 stocks rather than the 50-80 holdings common among category peers. This concentration is a deliberate expression of conviction. If a stock makes it into a portfolio of 30 names, it receives meaningful weight and the investment team takes genuine accountability for the thesis.
Compare this to diversified portfolios of 80+ stocks where many holdings receive 0.5%-1% weights positions so small they cannot meaningfully move the portfolio even if the thesis is entirely correct yet contribute to tracking error and noise without real upside. Motilal Oswal's concentrated approach means the fund will diverge significantly from benchmarks in both directions. It can dramatically outperform when high-conviction bets validate but can also underperform meaningfully when sector positioning doesn't align with short-term market leadership.
This fund is explicitly not for conservative equity investors seeking smooth, consistent returns regardless of market conditions. The concentrated portfolio, high technology allocation, premium valuation positioning, and significant sector-level conviction bets mean drawdowns during adverse periods can be steep and prolonged.
The fund's recent 18.81% debt allocation is worth examining carefully. This isn't defensive conservatism but a reflection of regulatory mechanics where certain types of instruments are categorized as debt in portfolio reporting while actually functioning as structured equity exposure or awaiting deployment.